Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting
Published
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #ASGCT--First look at preclinical data from DLVR-M, Nvelop's humanized particle platform for in vivo delivery of therapeutic cargoes.
Full Article